Cutter learned that the French were offered heat-treated product by Hyland and Behringwerke earlier in 1983. As a result the French had stopped all imports "until they can evaluate the information and offers they have received insofar as they relate to the hepatitis and AIDS questions."
Linked evidence
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates